{{Rsnum
|rsid=6856328
|Gene=LPHN3
|Chromosome=4
|position=61571600
|Orientation=plus
|GMAF=0.06198
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=LPHN3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 58.5 | 35.4 | 6.1
| ASW | 49.1 | 49.1 | 1.8
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 99.0 | 1.0 | 0.0
| LWK | 44.5 | 45.5 | 10.0
| MEX | 98.3 | 1.7 | 0.0
| MKK | 53.2 | 42.9 | 3.8
| TSI | 99.0 | 1.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21107309
|Trait=None
|Title=Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
|RiskAllele=
|Pval=8E-7
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}